Three endpoints of in vivo tumour radiobiology and their statistical estimation

References

• Alley MC, Hollingshead MG, Dykes DJ, Waud WR. 2004. Human tumor xenograft models in NCI drug development. In: Teicher BA, Andrews PA, editors. Anticancer drug development guide. 2nd ed. Totowa, NJ: Human Press. pp 125–152.
   Google Scholar
• Banks RB. 1994. Growth and diffusion phenomena. Berlin: Springer-Verlag.
   Google Scholar
• Bassukas ID. 1993. A generalized tumor-growth delay assay for quantifying alterations of tumor regrowth patterns. Anticancer Research 13:1601–1606.
   PubMed Web of Science ®Google Scholar
• Bassukas ID, Hofmockel G. 2001. Nobody needs “relative tumour sizes” to compare tumour growth curves. Anticancer Research 21:1181–1182.
   PubMed Web of Science ®Google Scholar
• Begg AC. 1980. Analysis of growth delay data: Potential pitfalls. British Journal of Cancer 41:1639–1643.
   Web of Science ®Google Scholar
• Begg AC. 1987. Principles and practices of the tumor growth delay assay. In: Kallman RF, editor. Rodent tumor models in experimental cancer therapy. New York: McGraw-Hill. pp 114–121.
   Google Scholar
• Bissery M-C, Guenard D, Gueritte-Voegeleina F, Lavelle F. 1991. Experimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue. Cancer Research 51:4845–4852.
   PubMed Web of Science ®Google Scholar
• Castorina P, Deisboeck TS, Gabriele P, Guiot C. 2007. Growth laws in cancer: Implication for radiotherapy. Radiation Research 168:349–356.
   PubMed Web of Science ®Google Scholar
• Demidenko E. 2004. Mixed models: Theory and applications. New York: Wiley.
   Google Scholar
• Demidenko E. 2006. The assessment of tumour response to treatment. Applied Statistics 55:365–377.
   Web of Science ®Google Scholar
• Denekamp J. 1974. The response of a mouse sarcoma to single and divided doses of X-rays and fast neutrons. British Journal of Cancer 29:292–299.
   PubMed Web of Science ®Google Scholar
• Hall EJ. 2000. Radiobiology for the radiobiologist. 5th ed. Philadelphia: Lippincott.
   Google Scholar
• Hanfelt JJ. 1997. Statistical approaches to experimental design and data analysis of in vivo studies. Breast Cancer Research and Treatment 46:279–302.
   PubMed Web of Science ®Google Scholar
• Heitjan DF, Manni A, Santen RJ. 1993. Statistical analysis of in vivo tumor growth experiments. Cancer Research 53:6042–6050.
   PubMed Web of Science ®Google Scholar
• Hou H, Khan N, Grinberg O, Yu H, Grinberg S, Lu S, Demidenko E, Steffen RP, Swartz HM. 2007. The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice. Radiation Research 168:218–225.
   PubMed Web of Science ®Google Scholar
• Jones DS, Sleeman DS. 2003. Differential equations and mathematical biology. London: Chapman & Hall/CRC.
   Google Scholar
• Kallman RF. 1987. Rodent tumor models in experimental cancer therapy. New York: Pergamon Press.
   Google Scholar
• Laird AK. 1983. Dynamics of tumour growth. British Journal of Cancer 18:490–502.
   Google Scholar
• Norton L, Simon R, Brereton HD, Bogden AE. 1976. Predicting the course of Gompertzian growth. Nature 264:542–545.
   PubMed Web of Science ®Google Scholar
• Ozono S, Miyao N, Igarashi T, Marumo K, Nakazawa H, Fukuda M, Tsushima T, Tokuda N, Kawamura J, Murai M. 2004. Tumor doubling time of renal cell carcinoma measured by CT: Collaboration of Japanese Society of Renal Cancer. Japanese Journal of Clinical Oncology 34:82–85.
   PubMed Web of Science ®Google Scholar
• Papadopoulou MV, Ji M, Ji X, Bloomer WD, Hollingshead MG. 2002. Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice. Cancer Chemotherapy and Pharmacology 50:501–508.
   PubMed Web of Science ®Google Scholar
• Rygaard K, Spang-Thomsen M. 1997. Quantitation and Gompertzian analysis of tumor growth. Breast Cancer Research and Treatment 46:303–312.
   PubMed Web of Science ®Google Scholar
• Sakamoto K. 2004. Radiobiological basis for cancer therapy by total or half-body irradiation. Nonlinearity in Biology, Toxicology and Medicine 2:293–316.
   PubMedGoogle Scholar
• Steel GG. 1977. Growth kinetics of tumours. Oxford: Clarendon Press.
   Google Scholar
• Thomlinson RH, Graddock EA. 1967. The gross response of an experimental tumour to single doses of X-rays. British Journal of Cancer 21:108–123.
   PubMed Web of Science ®Google Scholar
• Tomimaru Y, Noura S, Ohue M, Okami J, Oda K, Higashiyama M, Yamada T, Miyashiro I, Ohigashi H, Yano M, Kodama K, Ishikawa O, Murata K, Yokouchi H, Sasaki Y, Kameyama M, Imaoka S. 2008. Metastatic tumor doubling time is an independent predictor of intrapulmonary recurrence after pulmonary resection of solitary pulmonary metastasis from colorectal cancer. Digestive Surgery 25:220–225.
   PubMed Web of Science ®Google Scholar
• Yu RX, Holmgren RX. 2007. Endpoints for agents that slow tumor growth. Contemporary Clinical Trials 28:18–24.
   PubMed Web of Science ®Google Scholar
• Zhou XD, Pogue BW, Chen B, Demidenko E, Joshi R, Hoopes J, Hasan T. 2006. Pretreatment photosensitizer dosimetry reduces variation in tumor response. International Journal of Radiation Oncology Biology Physics 64:1211–1220.
   PubMed Web of Science ®Google Scholar